{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:55:03Z","timestamp":1775228103640,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003825.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T00:00:00Z","timestamp":1432252800000}}],"reference-count":73,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003825.pub4","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T16:29:55Z","timestamp":1432312195000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Blood pressure-lowering efficacy of loop diuretics for primary hypertension"],"prefix":"10.1002","volume":"2015","author":[{"given":"Vijaya M","family":"Musini","sequence":"first","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Science Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouria","family":"Rezapour","sequence":"additional","affiliation":[{"name":"University of British Columbia; Faculty of Medicine; Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Science Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Bassett","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Science Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciprian D","family":"Jauca","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Science Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,5,22]]},"reference":[{"key":"10.1002\/14651858.CD003825.pub4-BIB0001|cit1","first-page":"101","article-title":"Efficacy and tolerance of cicletanine in arterial hypertension of the elderly","volume":"44","author":"Bodak","year":"1989","journal-title":"Therapie"},{"issue":"11","key":"10.1002\/14651858.CD003825.pub4-BIB0002|cit2","first-page":"377","article-title":"Duration of antihypertensive effectiveness during therapy with cicletanine in ambulatory 24-h blood pressure measurement","volume":"26","author":"Gotzen","year":"1994","journal-title":"Herz\/Kreisl"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0002-9149(93)90882-D","article-title":"Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial","volume":"72","author":"Homuth","year":"1993","journal-title":"The American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/j.1875-9114.1984.tb03375.x","article-title":"Antihypertensive and biochemical effects of indacrinone enantiomers","volume":"4","author":"Jain","year":"1984","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003825.pub4-BIB0005|cit5","first-page":"263","article-title":"Clinical and hemodynamic effects of etozolin in essential hypertension: a double blind controlled trial","volume":"45","author":"Licata","year":"1989","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub4-BIB0006|cit6","first-page":"545","article-title":"Metabolic effects of furosemide and the combination of furosemide and triamterene","volume":"37","author":"Perola","year":"1985","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/030006058201000401","article-title":"Experience with once daily and twice daily slow release frusemide in hypertension","volume":"10","author":"Vadasz","year":"1982","journal-title":"Journal of International Medical Research"},{"issue":"5","key":"10.1002\/14651858.CD003825.pub4-BIB0008|cit8","first-page":"385","article-title":"Piretanide in the treatment of essential hypertension. A double blind comparison versus placebo","volume":"XII","author":"Verho","year":"1986","journal-title":"Drugs Under Experimental and Clinical Research"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archinte.1971.00310170142020","article-title":"Furosemide in essential hypertension. A statistical analysis of three double blind studies","volume":"127","author":"Wertheimer","year":"1971","journal-title":"Archives Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1185\/03007998109114270","article-title":"Comparison of antihypertensive activities of xipamid and chlorthalidone: a double blind randomized cross over trial","volume":"7","author":"Bonaduce","year":"1981","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/030006058401200203","article-title":"A double blind multicentre study of piretanide and hydrochlorothiazide in patients with essential hypertension","volume":"12","author":"Buckert","year":"1984","journal-title":"Journal of International Medical Research"},{"issue":"13","key":"10.1002\/14651858.CD003825.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archinte.158.13.1461","article-title":"Fluctuations in blood lipid levels during furosemide therapy","volume":"158","author":"Campbell","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0013|cit13","first-page":"169","article-title":"The Eurieve Study: contrasting effect of piretanide and thiazides in mild to moderate hypertension","volume":"52","author":"Charansonney","year":"1997","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0014|cit14","first-page":"1293","article-title":"Efficacy and tolerance of cicletanine added to a previous beta blocking therapy in essential hypertensive patients","volume":"82","author":"Clerson","year":"1989","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0015|cit15","first-page":"A97","article-title":"Evaluation of the effects of prolonged release torasemide versus furosemide on myocardial fibrosis (Torafic Study): Design and baseline characteristics","volume":"1","author":"Coca","year":"2009","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","article-title":"Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure","volume":"290","author":"Costello-Boerrigter","year":"2006","journal-title":"American Journal of Physiology - Renal Physiology"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1586\/erc.09.74","article-title":"TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure","volume":"7","author":"Diez","year":"2009","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub4-BIB0018|cit18","first-page":"1044","article-title":"The hemodynamic effect of etozolin in the treatment of hypertension","volume":"48","author":"Somma","year":"1990","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0019|cit19","doi-asserted-by":"crossref","unstructured":"Drolet DW Coar W Boinpally R Walker G Effect on peripheral blood pressure of a single oral dose of cicletanine HCl alone or in the presence of steady state sildenafil in healthy adult subjects American Journal of Respiratory and Critical Care Medicine 2010 A3331","DOI":"10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A3331"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/ndt\/gfl133","article-title":"A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients","volume":"21","author":"Dussol","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003825.pub4-BIB0021|cit21","first-page":"92","article-title":"Tienilic acid in the treatment of hypertension. Double blind assessment of tienilic acid in essential hypertension","volume":"55","author":"Fried","year":"1979","journal-title":"Postgraduate Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD003825.pub4-BIB0022|cit22","first-page":"159","article-title":"Diuretic therapy for mild hypertension: A comparison of the metabolic effects of etozoline and chlorthalidone during long term treatment","volume":"50","author":"Galleti","year":"1991","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2006.00606.x","article-title":"Dosage dependent hormonal counter regulation to combination therapy in patients with left ventricular dysfunction","volume":"31","author":"Galloe","year":"2006","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub4-BIB0024|cit24","first-page":"468","article-title":"Piretanide (HOE118): A new diuretic in essential hypertension","volume":"30","author":"Gupta","year":"1981","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/eurjhf\/hfq090","article-title":"The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction","volume":"12","author":"Gupta","year":"2010","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/j.1552-4604.1998.tb04470.x","article-title":"A randomized placebo controlled study of loop diuretics in patients with essential hypertension: the bumetanide and furosemide on lipid profile (BUFUL) clinical study report","volume":"38","author":"Heijden","year":"1998","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archinte.1979.03630490029011","article-title":"Role of renin classification for diuretic treatment of black hypertensive patients","volume":"139","author":"Holland","year":"1979","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0028|cit28","first-page":"792","article-title":"Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring","volume":"29","author":"Hua","year":"2007","journal-title":"Chung-Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Iyalomhe GBS Omogbai EKI Ozolua RI Antihypertensive and some biochemical effects of hydrochlorothiazide and furosemide in some Nigerians Journal of Medical Sciences 2007 977 83","DOI":"10.3923\/jms.2007.977.983"},{"issue":"IV","key":"10.1002\/14651858.CD003825.pub4-BIB0030|cit30","first-page":"125","article-title":"Dosage study of cicletanine in elderly hypertensive patients: comparison of 50 vs 100mg daily dose","volume":"82","author":"Jungers","year":"1989","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub4-BIB0031|cit31","first-page":"281","article-title":"Clinical experience with a fixed dose combination of penbutolol and furosemide in hypertension","volume":"31","author":"Knobem","year":"1982","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0032|cit32","first-page":"1194","article-title":"The antihypertensive effect of etozolin","volume":"22","author":"Kopp","year":"1978","journal-title":"Fortschr. Med.96.jg."},{"key":"10.1002\/14651858.CD003825.pub4-BIB0033|cit33","first-page":"110","article-title":"Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double blind cross over study with cyclopenthiazide","volume":"602","author":"Krogsgaard","year":"1976","journal-title":"Acta Medica Scandinavica Supplementum"},{"issue":"10","key":"10.1002\/14651858.CD003825.pub4-BIB0034|cit34","first-page":"349","article-title":"A randomized double blind clinical trial of xipamid and hydrochlorothiazide in essential hypertension","volume":"22","author":"Kumar","year":"1984","journal-title":"International Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0035|cit35","unstructured":"Kundu SC Bhattacharya Td Vakil HB Diurnal pattern of blood pressure response to furosemide Indian Practitioner 1986 757 65"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3143\/geriatrics.22.346","article-title":"Comparison of clinical usefulness of diuretics in elderly and younger essential hypertension - double blind trial using tripamide","volume":"22","author":"Kuramoto","year":"1985","journal-title":"Jpn J Geriat"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hep.1840130616","article-title":"Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study","volume":"13","author":"Laffi","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Leitch AG Clancy L Flenley DC The effect of bendrofluazide and frusemide on the ventilatory response to carbon dioxide and hypoxia in normal man Clinical Science and Molecular Medicine 1974 377 85","DOI":"10.1042\/cs0470377"},{"issue":"suppl 3A","key":"10.1002\/14651858.CD003825.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0002-9343(88)90205-7","article-title":"Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve","volume":"84","author":"Magrini","year":"1988","journal-title":"The American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003825.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/01443619750114040","article-title":"A randomised placebo controlled trial of loop diuretics in moderate\/severe pre-eclampsia, following delivery","volume":"17","author":"Matthews","year":"1997","journal-title":"Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0041|cit41","first-page":"523","article-title":"Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure","volume":"2","author":"Mitrovic","year":"2009","journal-title":"Circulation: Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub4-BIB0042|cit42","first-page":"773","article-title":"Comparative double blind trial with long acting furosemide and chlorthalidone in the treatment of essential hypertension","volume":"85","author":"Miziara","year":"1982","journal-title":"Farmacologica Clinica"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0043|cit43","first-page":"157","article-title":"Acute antihypertensive, diuretic and metabolic effect of etozolin and chlorthalidone","volume":"33","author":"Nami","year":"1991","journal-title":"Panminerva Medica"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub4-BIB0044|cit44","first-page":"443","article-title":"Comparison of slow release frusemide and bendrofluazide in the treatment of moderate hypertension in Kenyan Negroes","volume":"21","author":"Obel","year":"1984","journal-title":"Clinical Trials Journal"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cpt1978236703","article-title":"Tricynafen and hydrochlorothiazide in hypertension","volume":"23","author":"Okun","year":"1978","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003825.pub4-BIB0046|cit46","first-page":"103","article-title":"A double-blind study of tienilic acid with two year follow-up of patients with mild to moderate essential hypertension","volume":"55","author":"Okun","year":"1979","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub4-BIB0047|cit47","first-page":"537","article-title":"Sustained release frusemide and blood glucose levels in diabetics","volume":"34","author":"Oli","year":"1983","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD003825.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005344-198101000-00014","article-title":"Involvement of kallikrein in the antihypertensive response to furosemide in essential hypertension","volume":"3","author":"Olshan","year":"1981","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"8118","key":"10.1002\/14651858.CD003825.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(79)91149-8","article-title":"Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension","volume":"1","author":"Pearson","year":"1979","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub4-BIB0050|cit50","first-page":"115","article-title":"Propranolol and tienilic acid in essential hypertension","volume":"55","author":"Pearson","year":"1979","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0051|cit51","first-page":"127","article-title":"Atenolol improves blood pressure control in patients taking captopril and frusemide","volume":"1","author":"Potter","year":"1987","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD003825.pub4-BIB0052|cit52","first-page":"183","article-title":"Hydrochlorothiazide versus a non-diuretic dose of torasemide as once daily antihypertensive monopharmacotherapy in elderly patients. A randomized double blind study.","volume":"8","author":"Reyes","year":"1990","journal-title":"Progress in Pharmacology and Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub4-BIB0053|cit53","first-page":"492","article-title":"Adding muzolimine or triamterene to nifedipine: effect on blood pressure","volume":"48","author":"Ronchi","year":"1990","journal-title":"Current Therapeutic Research"},{"issue":"(1 Pt 1)","key":"10.1002\/14651858.CD003825.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0022-3476(05)82458-8","article-title":"Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia","volume":"117","author":"Rush","year":"1990","journal-title":"The Journal of Pediatrics"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0002-9149(88)90549-8","article-title":"Effect of intravenous enalaprilat in moderate and severe systemic hypertension","volume":"62","author":"Rutledge","year":"1988","journal-title":"The American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1016\/S0735-1097(11)60216-7","article-title":"Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from DOSE-AHF","volume":"1","author":"Shah","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2011.08.005","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction","volume":"17","author":"Udelson","year":"2011","journal-title":"Journal of Cardiac Failure"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0058|cit58","first-page":"296","article-title":"Treatment of benign essential hypertension with frusemide in different doses","volume":"2","author":"Valmin","year":"1980","journal-title":"Pharmacotherapeutica"},{"issue":"1","key":"10.1002\/14651858.CD003825.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1388-9842(02)00205-2","article-title":"Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function","volume":"5","author":"Kraaij","year":"2003","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0060|cit60","first-page":"121","article-title":"Atenolol or propanolol in hypertensive patients poorly controlled on captopril and frusemide","volume":"1","author":"Webster","year":"1987","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD003825.pub4-BIB0061|cit61","first-page":"109","article-title":"Diuretic and anti-hypertensive effects of indapalide. Comparison with furosemide","volume":"29","author":"Witchitz","year":"1974","journal-title":"Therapie"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1185\/03007998709111109","article-title":"Efficacy of a fixed dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double blind study against placebo","volume":"10","author":"Yasky","year":"1987","journal-title":"Curr. Med. Res. Opi."},{"issue":"9","key":"10.1002\/14651858.CD003825.pub4-BIB0063|cit63","first-page":"607","article-title":"Efficacy of a low dose fixed combination of penbutolol and piretanide in the treatment of mild to moderate hypertension: a double blind study against placebo","volume":"4","author":"Yasky","year":"1986","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/ndt\/gfq565","article-title":"Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial","volume":"26","author":"Zamboli","year":"2011","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub4-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007187.pub2","article-title":"Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension","author":"Chen","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub4-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003823.pub2","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub4-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003822.pub2","article-title":"Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-8703(83)90117-5","article-title":"Insights into intrarenal sites and mechanism of action of diuretic agents","volume":"106","author":"Materson","year":"1983","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub4-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007066.pub2","article-title":"Blood pressure lowering efficacy of renin inhibitors for primary hypertension","author":"Musini","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003825.pub4-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"e5673","DOI":"10.1371\/journal.pone.0005673","article-title":"Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials\u00a0","volume":"4","author":"Musini","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0071|cit71","unstructured":"Nordic Cochrane Centre Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD003825.pub4-BIB0072|cit72","volume-title":"Diuretic Agents: Clinical Physiology and Pharmacology","author":"Seldin","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub4-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001841.pub2","article-title":"First-line drugs for hypertension","author":"Wright","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003825.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T11:00:14Z","timestamp":1698145214000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003825.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,22]]},"references-count":73,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003825.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,22]]}}}